ISIN | AT0000A0XMM2 |
---|---|
Valor Number | 19994591 |
Bloomberg Global ID | |
Fund Name | DSC Equity Fund – Healthcare A |
Fund Provider |
Dreyfus Söhne & Cie AG, Banquiers
Aeschenvorstadt 16 | Postfach 4051 Basel Schweiz Phone: +41 61 286 66 66 Web: https://www.dreyfusbank.ch |
Fund Provider | Dreyfus Söhne & Cie AG, Banquiers |
Representative in Switzerland |
Dreyfus Söhne & Cie AG, Banquiers Basel |
Distributor(s) |
Dreyfus Söhne & Cie AG, Banquiers Basel |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Austria |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | N/A |
Peculiarities |
Current Price * | 197.35 CHF | 03.10.2025 |
---|---|---|
Previous Price * | 197.17 CHF | 02.10.2025 |
52 Week High * | 236.01 CHF | 15.10.2024 |
52 Week Low * | 180.97 CHF | 08.08.2025 |
NAV * | 197.35 CHF | 03.10.2025 |
Issue Price * | 203.28 CHF | 03.10.2025 |
Redemption Price * | 197.35 CHF | 03.10.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 33,807,437 | |
Unit/Share Assets *** | 1,211,268 | |
Trading Information SIX |
YTD Performance | -9.31% |
30.12.2024 - 03.10.2025
30.12.2024 03.10.2025 |
---|---|---|
1 month | +3.29% |
03.09.2025 - 03.10.2025
03.09.2025 03.10.2025 |
3 months | +5.06% |
03.07.2025 - 03.10.2025
03.07.2025 03.10.2025 |
6 months | -9.83% |
03.04.2025 - 03.10.2025
03.04.2025 03.10.2025 |
1 year | -14.30% |
03.10.2024 - 03.10.2025
03.10.2024 03.10.2025 |
2 years | -6.13% |
03.10.2023 - 03.10.2025
03.10.2023 03.10.2025 |
3 years | -5.89% |
03.10.2022 - 03.10.2025
03.10.2022 03.10.2025 |
5 years | -6.10% |
05.10.2020 - 03.10.2025
05.10.2020 03.10.2025 |
Equity Participation Rate in % | 97.45 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
iShares MSCI Wld HlthCrSect AdvcdETF$Inc | 7.83% | |
---|---|---|
Johnson & Johnson | 7.30% | |
Eli Lilly and Co | 6.02% | |
Abbott Laboratories | 4.70% | |
AbbVie Inc | 4.33% | |
Merck & Co Inc | 3.64% | |
AstraZeneca PLC | 3.52% | |
UnitedHealth Group Inc | 3.28% | |
Sanofi SA | 3.00% | |
Thermo Fisher Scientific Inc | 2.86% | |
Last data update | 31.07.2025 |
TER | 1.49% |
---|---|
TER date | 30.04.2025 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.50% |
Ongoing Charges *** | 1.49% |
SRRI ***
|
|
SRRI date *** | 31.08.2025 |